1-3 of 3
Elaine Allan
Close
Sort by
Journal Articles

Foxo Transcription Factor Activity Is Retained in Quiescent Chronic Myeloid Leukaemia Stem Cells and Activated by Tyrosine Kinase Inhibitors to Mediate “induced-quiescence” in More Mature progenitors.

Daniela Cilloni, MD, PhD, Francesca Pellicano, PhD, Vignir G Helgason, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Brian J Huntly, MD, Elaine Allan, PhD, Francesca Arruga, PhD, Enrico Bracco, PhD, Giuseppe Saglio, MD, Tessa L Holyoake, MD
Journal: Blood
Blood (2009) 114 (22): 187.
https://doi.org/10.1182/blood.V114.22.187.187
Published: 2009
Journal Articles

Growth Factor Deprivation Combined with Prolonged Inhibition of BCR-ABL Does Not Eradicate Functional CML Stem Cells

Ashley Hamilton, Gudmundur V Helgason, Elaine Allan, Michael J. Alcorn, PhD, Franck E Nicolini, MD, PhD, Allison Blair, PhD, BSc, Mirle Schemionek, Steffen Koschmieder, MD, Valerie G Brunton, Tessa L Holyoake
Journal: Blood
Blood (2008) 112 (11): 4222.
https://doi.org/10.1182/blood.V112.11.4222.4222
Published: 2008
Journal Articles

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

Susan M. Graham, Heather G. Jørgensen, Elaine Allan, Charlie Pearson, Michael J. Alcorn, Linda Richmond, Tessa L. Holyoake
Journal: Blood
Blood (2002) 99 (1): 319–325.
https://doi.org/10.1182/blood.V99.1.319
Published: 2002